logo
Welcome Guest! To enable all features please Login or Register.

Notification

Icon
Error

Login


Options
View
Go to last post Go to first unread
NoRx Pharmacy  
#1 Posted : Tuesday, October 27, 2020 4:35:33 PM(UTC)
NoRx Pharmacy

Rank: Newbie

Groups: Registered
Joined: 10/27/2020(UTC)
Posts: 3
United States
Location: Florida

Soma or carisoprodol tablets are available in white round tablet strengths of 250 mg and 350 mg.
Carisoprodol, the active ingredient in soma, is a white crystalline powder with a moderate, distinctive smell and a slightly bitter taste.
Lightly soluble in water, the substance is freely soluble in chloroform, alcohol, and acetone.

Carisoprodol is a combination of racemics.Magnesium stearate, alginic acid, starch, potassium sorbate and
tribas are the inactive components found in soma.

Indication

Purchase soma online for pain relief and irritation in adults associated with acute skeletal muscle conditions. The use of medication is short term.

Doctors only recommend soma for a span of between 2 and 14 days.
This is due to several factors:

The efficacy of soma beyond two weeks is not known by any research. Long term use of carisoprodol can lead to dependency, leading to addiction and withdrawal of soma.
Musculoskeletal disorders are often short-lived and last no longer.

UserPostedImage

One tablet of soma 250 mg or soma 350 mg three times a day and once at bedtime is to
recomended daily dose of soma. For soma therapy, the maximum time is two to three weeks.

Dosage and Administration

Soma is an oral tablet that should be taken by mouth. With enough water to drink it smoothly, take the pill as a whole.
Soma 250 mg: convex tablets, round, white, imprinted with SOMA 250 Soma 350 mg: convex tablets, round, white, imprinted with SOMA 350Storage How to supply Soma 250 mg: convex tablets, round, white, imprinted with SOMA 350

Storage

Store soma pills at a controlled room temperature of 20 to 25 degree Celsius (68-77 degrees Fahrenheit)
Since clinical investigations are performed under generally changing circumstances, unfavorable response rates seen in drug clinical trials can not be explicitly compared with rates in other clinical medicine investigations. They do not practically reflect the rates seen.

The information below depends on 1387 patients pooled from two double visually impaired, randomized, multicenter, controlled fake therapy, one week preliminaries in severe, adult patients.
Users browsing this topic
Guest
Forum Jump  
You cannot post new topics in this forum.
You cannot reply to topics in this forum.
You cannot delete your posts in this forum.
You cannot edit your posts in this forum.
You cannot create polls in this forum.
You cannot vote in polls in this forum.